OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of sacubitril valsartan on cardiac function and endothelial function in patients with chronic heart failure with reduced ejection fraction
Baohua Li, Kuaifa Fang, Lin Pei-huan, et al.
Clinical Hemorheology and Microcirculation (2020) Vol. 77, Iss. 4, pp. 425-433
Closed Access | Times Cited: 7
Baohua Li, Kuaifa Fang, Lin Pei-huan, et al.
Clinical Hemorheology and Microcirculation (2020) Vol. 77, Iss. 4, pp. 425-433
Closed Access | Times Cited: 7
Showing 7 citing articles:
Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure
Vasiliki Tsigkou, Evangelos Oikonomou, Artemis Anastasiou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4321-4321
Open Access | Times Cited: 29
Vasiliki Tsigkou, Evangelos Oikonomou, Artemis Anastasiou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4321-4321
Open Access | Times Cited: 29
Pharmacotherapy in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis
Jia Tang, Ping Wang, Chenxi Liu, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 5
Jia Tang, Ping Wang, Chenxi Liu, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 5
Effects of sacubitril-valsartan in Patients with Various Types of Heart Failure: A Meta-Analysis
Hongyu Zhang, Abigail T. Huetteman, Eduardo Reyes, et al.
Journal of Cardiovascular Pharmacology (2023) Vol. 81, Iss. 6, pp. 434-444
Open Access | Times Cited: 5
Hongyu Zhang, Abigail T. Huetteman, Eduardo Reyes, et al.
Journal of Cardiovascular Pharmacology (2023) Vol. 81, Iss. 6, pp. 434-444
Open Access | Times Cited: 5
Peptides from Harpadon nehereus Bone Ameliorate Angiotensin II-Induced HUVEC Injury and Dysfunction through Activation of the AKT/eNOS and Nrf2 Pathway
Manfen Shao, Wei Zhao, Kai Shen, et al.
ACS Omega (2023) Vol. 8, Iss. 44, pp. 41655-41663
Open Access | Times Cited: 5
Manfen Shao, Wei Zhao, Kai Shen, et al.
ACS Omega (2023) Vol. 8, Iss. 44, pp. 41655-41663
Open Access | Times Cited: 5
LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice
Uugantsetseg Munkhjargal, Daiju Fukuda, Juri Maeda, et al.
Journal of Atherosclerosis and Thrombosis (2024) Vol. 31, Iss. 9, pp. 1333-1340
Open Access | Times Cited: 1
Uugantsetseg Munkhjargal, Daiju Fukuda, Juri Maeda, et al.
Journal of Atherosclerosis and Thrombosis (2024) Vol. 31, Iss. 9, pp. 1333-1340
Open Access | Times Cited: 1
Comparative effects of sacubitril/valsartan and ACEI/ARB on endothelial function and arterial stiffness in patients with heart failure: a protocol for systematic review and meta-analysis
Zhiyong Ma, Zhijie Fu, Na Li, et al.
BMJ Open (2024) Vol. 14, Iss. 9, pp. e088744-e088744
Open Access
Zhiyong Ma, Zhijie Fu, Na Li, et al.
BMJ Open (2024) Vol. 14, Iss. 9, pp. e088744-e088744
Open Access
Efficacy and safety profile of angiotensin receptor neprilysin inhibitors in the management of heart failure: a systematic review and meta-analysis of randomized controlled trials
Juan Gao, Cong Zhao, Wenzhong Zhang, et al.
Heart Failure Reviews (2022) Vol. 28, Iss. 4, pp. 905-923
Open Access | Times Cited: 2
Juan Gao, Cong Zhao, Wenzhong Zhang, et al.
Heart Failure Reviews (2022) Vol. 28, Iss. 4, pp. 905-923
Open Access | Times Cited: 2
